Patents by Inventor Petra Leidinger
Petra Leidinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11111541Abstract: The invention relates to methods for diagnosing Parkinson's Disease PAD) with miRNA markers. Towards the identification of biomarkers for diagnosis of PD, a comprehensive analysis of miRNA expression patterns was obtained. Significantly deregulated miRNAs were identified.Type: GrantFiled: June 11, 2018Date of Patent: September 7, 2021Assignee: Universitat Des SaarlandesInventors: Andreas Keller, Cord Friedrich Stahler, Jan Kirsten, Eckart Meese, Christina Backes, Petra Leidinger
-
Patent number: 10457988Abstract: The invention relates to novel miRNA markers useful for diagnosis or therapy of disease, in particular for neuronal disorders such as Alzheimer's Disease (AD).Type: GrantFiled: November 4, 2013Date of Patent: October 29, 2019Assignee: Siemens AktiengesellschaftInventors: Andreas Keller, Cord Friedrich Stähler, Christina Backes, Eckart Meese, Petra Leidinger, Andreas Kappel
-
Patent number: 10161004Abstract: The invention relates to methods for diagnosing multiple sclerosis with miRNA markers. Diagnosis of multiple sclerosis (MS) can be challenging in patients with atypical presentations and during a first neurological deficit possibly related to inflammatory demyelination. Towards the identification of biomarkers for diagnosis of MS, a comprehensive analysis of miRNA expression patterns was obtained. Significantly deregulated miRNAs were identified, which have previously not been related to MS according to the microRNA disease database. These miRNAs could potentially serve as future diagnostic biomarkers for MS and help in diagnosis, monitoring disease activity, and evaluation of treatment responses in patients with MS.Type: GrantFiled: April 18, 2013Date of Patent: December 25, 2018Assignee: Siemens AktiengesellschaftInventors: Andreas Keller, Eckart Meese, Cord Friedrich Stähler, Andreas Kappel, Petra Leidinger, Christina Backes
-
Publication number: 20180340228Abstract: The invention relates to methods for diagnosing Parkinson's Disease PAD) with miRNA markers. Towards the identification of biomarkers for diagnosis of PD, a comprehensive analysis of miRNA expression patterns was obtained. Significantly deregulated miRNAs were identified.Type: ApplicationFiled: June 11, 2018Publication date: November 29, 2018Inventors: ANDREAS KELLER, Cord Friedrich Stahler, Jan Kirsten, Eckart Meese, Christina Backes, Petra Leidinger
-
Patent number: 10138520Abstract: The invention relates to methods for diagnosing Alzheimer's Disease (AD) with miRNA markers. Diagnosis of AD Towards the identification of biomarkers for diagnosis of AD, a comprehensive analysis of miRNA expression patterns was obtained. Significantly deregulated miRNAs were identified.Type: GrantFiled: October 29, 2013Date of Patent: November 27, 2018Assignee: SIEMENS AKTIENGESELLSCHAFTInventors: Andreas Keller, Cord Friedrich Stähler, Eckart Meese, Andreas Kappel, Christina Backes, Petra Leidinger
-
Patent number: 10011873Abstract: The invention relates to methods for diagnosing Parkinson's Disease PAD) with miRNA markers. Towards the identification of biomarkers for diagnosis of PD, a comprehensive analysis of miRNA expression patterns was obtained. Significantly deregulated miRNAs were identified.Type: GrantFiled: July 26, 2013Date of Patent: July 3, 2018Assignee: UNIVERSITAT DES SAARLANDESInventors: Andreas Keller, Cord Friedrich Stähler, Jan Kirsten, Eckart Meese, Christina Backes, Petra Leidinger
-
Patent number: 9790554Abstract: The present invention relates to non-invasive methods, kits and means for diagnosing and/or prognosing of kidney cancer in a body fluid sample from a subject. Further, the present invention relates to set of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of kidney cancer in a body fluid sample from a subject. In addition, the present invention relates to sets of miRNAs for diagnosing and/or prognosing of kidney cancer in a body fluid sample from a subject.Type: GrantFiled: August 3, 2012Date of Patent: October 17, 2017Assignee: Hummingbird Diagnostics GmbHInventors: Andreas Keller, Markus Beier, Eckart Meese, Petra Leidinger, Anke Wendschlag
-
Publication number: 20170130269Abstract: The invention relates to a method of diagnosis of neuromyelitis optica, in particular of differential diagnosis of neuromyelitis optica (NMO) vs. multiple sclerosis (MS) using miRNA biomarkers. These miRNAs could potentially serve as future diagnostic biomarkers for NMO and help in diagnosis, monitoring disease activity, and evaluation of treatment responses in patients with MS.Type: ApplicationFiled: June 24, 2015Publication date: May 11, 2017Inventors: Andreas KELLER, Jan KIRSTEN, Cord Friedrich STAEHLER, Christina BACKES, Petra LEIDINGER, Eckart MEESE
-
Patent number: 9631241Abstract: Described herein are non-invasive methods, kits and means for diagnosing and/or prognosing of colon cancer a body fluid sample from a subject. Further described herein are sets of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject. In addition, described herein are sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject.Type: GrantFiled: January 21, 2016Date of Patent: April 25, 2017Assignee: Comprehensive Biomarker Center GmbHInventors: Andreas Keller, Markus Beier, Eckart Meese, Petra Leidinger, Anke Wendschlag
-
Publication number: 20160273040Abstract: The invention relates to methods for diagnosing Alzheimer's Disease (AD) with miRNA markers. Diagnosis of AD Towards the identification of biomarkers for diagnosis of AD, a comprehensive analysis of miRNA expression patterns was obtained. Significantly deregulated miRNAs were identified.Type: ApplicationFiled: October 29, 2013Publication date: September 22, 2016Inventors: Andreas KELLER, Cord Friedrich STÄHLER, Eckart MEESE, Andreas KAPPEL, Christina BACKES, Petra LEIDINGER
-
Publication number: 20160138117Abstract: Described herein are non-invasive methods, kits and means for diagnosing and/or prognosing of colon cancer a body fluid sample from a subject. Further described herein are sets of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject. In addition, described herein are sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject.Type: ApplicationFiled: January 21, 2016Publication date: May 19, 2016Applicant: Comprehensive Biomarker Center GmbHInventors: Andreas Keller, Markus Beier, Eckart Meese, Petra Leidinger, Anke Wendschlag
-
Patent number: 9249469Abstract: The present invention relates to non-invasive methods, kits and means for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject. Further, the present invention relates to set of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject. In addition, the present invention relates to sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject.Type: GrantFiled: August 3, 2012Date of Patent: February 2, 2016Assignee: Comprehensive Biomarker Center GmbHInventors: Andreas Keller, Markus Beier, Eckart Meese, Petra Leidinger, Anke Wendschlag
-
Publication number: 20150315641Abstract: The invention relates to methods for diagnosing Parkinson's Disease PAD) with miRNA markers. Towards the identification of biomarkers for diagnosis of PD, a comprehensive analysis of miRNA expression patterns was obtained. Significantly deregulated miRNAs were identified.Type: ApplicationFiled: July 26, 2013Publication date: November 5, 2015Inventors: Andreas KELLER, Cord Friedrich STÄHLER, Jan KIRSTEN, Eckart MEESE, Christina BACKES, Petra LEIDINGER
-
Publication number: 20150292013Abstract: The invention relates to novel miRNA markers useful for diagnosis or therapy of disease, in particular for neuronal disorders such as Alzheimer's Disease (AD).Type: ApplicationFiled: November 4, 2013Publication date: October 15, 2015Inventors: Andreas Keller, Cord Friedrich Stähler, Christina Backes, Eckart Meese, Petra Leidinger, Andreas Kappel
-
Publication number: 20150111772Abstract: The invention relates to methods for diagnosing multiple sclerosis with miRNA markers. Diagnosis of multiple sclerosis (MS) can be challenging in patients with atypical presentations and during a first neurological deficit possibly related to inflammatory demyelination. Towards the identification of biomarkers for diagnosis of MS, a comprehensive analysis of miRNA expression patterns was obtained. Significantly deregulated miRNAs were identified, which have previously not been related to MS according to the microRNA disease database. These miRNAs could potentially serve as future diagnostic biomarkers for MS and help in diagnosis, monitoring disease activity, and evaluation of treatment responses in patients with MS.Type: ApplicationFiled: April 18, 2013Publication date: April 23, 2015Applicant: Siemens Healthcare Diagnostics Holding GmbHInventors: Andreas Keller, Eckart Meese, Cord Friedrich Stähler, Andreas Kappel, Petra Leidinger, Christina Backes
-
Publication number: 20140274789Abstract: The present invention relates to non-invasive methods, kits and means for diagnosing and/or prognosing of psoriasis in a body fluid sample from a subject. Further, the present invention relates to set of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of psoriasis in a body fluid sample from a subject. In addition, the present invention relates to sets of miRNAs for diagnosing and/or prognosing of psoriasis in a body fluid sample from a subject.Type: ApplicationFiled: August 3, 2012Publication date: September 18, 2014Inventors: Andreas Keller, Markus Beier, Eckart Meese, Petra Leidinger, Valesca Boisguerin
-
Publication number: 20140213476Abstract: The present invention relates to non-invasive methods, kits and means for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject. Further, the present invention relates to set of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject. In addition, the present invention relates to sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject.Type: ApplicationFiled: August 3, 2012Publication date: July 31, 2014Inventors: Andreas Keller, Markus Beier, Eckart Meese, Petra Leidinger, Anke Wendschlag
-
Publication number: 20140193822Abstract: The present invention relates to non-invasive methods, kits and means for diagnosing and/or prognosing of kidney cancer in a body fluid sample from a subject. Further, the present invention relates to set of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of kidney cancer in a body fluid sample from a subject. In addition, the present invention relates to sets of miRNAs for diagnosing and/or prognosing of kidney cancer in a body fluid sample from a subject.Type: ApplicationFiled: August 3, 2012Publication date: July 10, 2014Applicant: Comprehensive Biomarker Center GmbHInventors: Andreas Keller, Markus Beier, Eckart Meese, Petra Leidinger, Anke Wendschlag
-
Publication number: 20130331278Abstract: The present invention relates to non-invasive methods, kits and means for diagnosing and/or prognosing of prostate diseases in a body fluid sample from a subject. Further, the present invention relates to set of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of prostate diseases in a body fluid sample from a subject. In addition, the present invention relates to sets of miRNAs for diagnosing and/or prognosing of prostate diseases in a body fluid sample from a subject.Type: ApplicationFiled: December 28, 2011Publication date: December 12, 2013Applicant: febit Holding GmbHInventors: Andreas Keller, Markus Beier, Valesca Boisguerin, Eckart Meese, Petra Leidinger